215 related articles for article (PubMed ID: 30854398)
1. How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities.
Wang YY; Li SW; Luo S; Qin L; Zeng X; Li L; Li XH
Biomed Res Int; 2019; 2019():6126808. PubMed ID: 30854398
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
Leerasiri P; Wongwananuruk T; Indhavivadhana S; Techatraisak K; Rattanachaiyanont M; Angsuwathana S
J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
5. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
Zore T; Lizneva D; Brakta S; Walker W; Suturina L; Azziz R
Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835
[TBL] [Abstract][Full Text] [Related]
6. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
11. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.
Asunción M; Calvo RM; San Millán JL; Sancho J; Avila S; Escobar-Morreale HF
J Clin Endocrinol Metab; 2000 Jul; 85(7):2434-8. PubMed ID: 10902790
[TBL] [Abstract][Full Text] [Related]
14. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovary syndrome and related disorders in mexican women.
Moran C; Tena G; Moran S; Ruiz P; Reyna R; Duque X
Gynecol Obstet Invest; 2010; 69(4):274-280. PubMed ID: 20110726
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
[TBL] [Abstract][Full Text] [Related]
17. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age.
Guo Z; Jin F; Chen S; Hu P; Hao Y; Yu Q
BMC Endocr Disord; 2023 Apr; 23(1):89. PubMed ID: 37088815
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
[TBL] [Abstract][Full Text] [Related]
19. Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study.
Rall K; Conzelmann G; Schäffeler N; Henes M; Wallwiener D; Möhrle M; Brucker SY
Reprod Biol Endocrinol; 2014 Mar; 12():23. PubMed ID: 24641817
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine.
Musmar S; Afaneh A; Mo'alla H
Reprod Biol Endocrinol; 2013 May; 11():47. PubMed ID: 23688000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]